Role of Ghrelin in the Pathophysiology of Eating Disorders: Implications for Pharmacotherapy

Author： >   Merkestein Myrte  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.26, Iss.4, 2012-04, pp. : 281-296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Towards the pharmacotherapy of eating disorders

By Pederson Kristine J   Roerig James L   Mitchell James E  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 10, 2003-10 ,pp. : 1659-1678

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy of Early Onset Eating Disorders

By  

Child and Adolescent Psychopharmacology News, Vol. 8, Iss. 6, 2003-09 ,pp. : 1-7

Guilford Publications Inc

Access to resources Recommend Favorite

Implications of Gliotransmission for the Pharmacotherapy of CNS Disorders

By Rossi Daniela   Martorana Francesca   Brambilla Liliana  

CNS Drugs, Vol. 25, Iss. 8, 2011-08 ,pp. : 641-658

Adis International

Access to resources Recommend Favorite

The Role of Blood-Brain Barrier Transporters in Pathophysiology and Pharmacotherapy of Stroke

By  

Current Pharmaceutical Design, Vol. 20, Iss. 10, 2014-03 ,pp. : 1510-1522

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Antiepileptic Drugs in the Management of Eating Disorders

By McElroy Susan L.   Guerdjikova Anna I.   Martens Brian   KeckJr Paul E.   Pope Harrison G.   Hudson James I.  

CNS Drugs, Vol. 23, Iss. 2, 2009-01 ,pp. : 139-156

Adis International

Access to resources Recommend Favorite